Investor Relations
Corporate Profile
Arcutis Biotherapeutics (NASDAQ: ARQT) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology.
The company’s strategy is to exploit recent innovations in inflammation and immunology to bring the best molecules to bear against validated physiologic targets known to treat dermatological diseases and disorders.
Latest Quarterly Earnings
News
Sep 16, 2020
Sep 15, 2020
Sep 08, 2020
Events
Sep 17, 2020 at 10:40 AM EDT
Aug 12, 2020 at 1:10 PM EDT
Jun 11, 2020 at 11:10 AM PDT